← Open Payments lookup

JENNIFER ONYEKONWU-MCGILL: Open Payments

NPI 1063686616 · CLAREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,709 in 226 payments from 17 companies in 2025. Trend: 2023 $4,785 · 2024 $4,945 · 2025 $4,709

Food & beverage: $4,592Education: $117
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.52$1,174
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$502
Otsuka America Pharmaceutical, Inc.22$455
Alkermes, Inc.24$450
Janssen Pharmaceuticals, Inc20$415
Neurocrine BioSciences, Inc.14$369
E.R. Squibb & Sons, L.L.C.13$354
ABBVIE INC.24$338
Axsome Therapeutics, Inc.11$179
Takeda Pharmaceuticals U.S.A., Inc.15$173

Products named: AUSTEDO XR, CAPLYTA, UZEDY, ARISTADA, INVEGA SUSTENNA, INGREZZA, REXULTI, VRAYLAR.

Industry payments across CA — which companies pay providers there.